# Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-pd-1-inhibitor-sintilimab-in-nsclc/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shugeng Gao,Ning Li,Shun‐Yu Gao,Qi Xue,Jianming Ying,Shuhang Wang,Xiuli Tao,Jun Zhao,Yousheng Mao,Bing Wang,Kang Shao,Wendong Lei,Dali Wang,Fang Lv,Liang Zhao,Fan Zhang,Ziran Zhao,Kai Su,Fengwei Tan,Yibo Gao,Nan Sun,Dawei Wu,Yue Yu,Yun Ling,Zhijie Wang,Chunjian Duan,Wei Tang,Lei Zhang,Shun He,Ning Wu,Jie Wang,Jie He |
| Citations | 418 |
| DOI | 10.1016/j.jtho.2020.01.017 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.jto.org/article/S1556086420300575/pdf |
| OpenAlex ID | https://openalex.org/W3005124847 |
| PMID | 32036071 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Jianming Ying](https://scholariq.org/researchers/jianming-ying/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)

## Paper topics

- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.